Risk of cognitive impairment with non-vitamin K antagonist oral anticoagulants in atrial fibrillation: Protocol for a systemic review of randomized controlled trials and real-world studies

BACKGROUND: The association between use of non-vitamin K antagonist oral anticoagulants (NOACs) with cognitive impairment in atrial fibrillation (AF) remains unknown. METHODS: An electronic search of Medline, Embase, Cochrane Library databases and ClinicalTrials.gov Website will be performed for ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Long, Zhang, Chi, Gu, Zhi-Chun, Lin, Hou-Wen, Liu, Xiao-Yan, Pu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112882/
https://www.ncbi.nlm.nih.gov/pubmed/30142865
http://dx.doi.org/10.1097/MD.0000000000012072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112882/
https://www.ncbi.nlm.nih.gov/pubmed/30142865
http://dx.doi.org/10.1097/MD.0000000000012072

Ejemplares similares